
FDA Updates Labels for Two Cholesterol-Lowering Agents
New bempedoic acid and bempedoic acid/ezetimibe labels add primary hyperlipidemia and remove the maximally tolerated statin requirement and statement on the effect on mortality.
Hyperlipidemia in Racial/Ethnic Minorities - Medscape
Hyperlipidemia is a powerful and extremely common risk factor for cardiovascular disease (CVD) among all racial/ethnic groups. However, there are certain racial/ethnic differences in the ...
Exercising With Hyperlipidemia: Prescription for Health - Medscape
Apr 12, 2010 · Hyperlipidemia, which is having blood cholesterol and/or triglyceride levels that are too high, is a risk factor for many forms of cardiovascular disease. Regular physical activity, …
Treatment of Hyperlipidemia in HIV-Infected Patients - Medscape
Apr 1, 2001 · The treatment of hyperlipidemia in HIV-infected patients is complicated by their need for antiretroviral drugs, which can contribute to lipid disorders themselves.
Study Finds Association Between Statins and Glaucoma - Medscape
Dec 18, 2024 · People with high cholesterol taking statins have a higher prevalence of glaucoma than those with elevated cholesterol but not taking the drug, a study found.
AACE Publishes Guideline on Drug Management of Dyslipidemia
Feb 13, 2025 · New dyslipidemia guidance from the American Association of Clinical Endocrinology focuses on newer medications and patient-important outcomes.
Hyperlipidemia Management Depends on the Details - Medscape
Apr 16, 2007 · Combined hyperlipidemia is defined as increased low-density lipoprotein (LDL) cholesterol, decreased high-density lipoprotein (HDL) cholesterol, and increased triglyceride …
ECG Challenge: Irregular Pulse and Asymptomatic - Medscape
Oct 24, 2025 · A 46-year-old with a history of diabetes and hyperlipidemia has an irregular pulse during a routine exam. What does his ECG show?
What Cardiologists Want PCPs to Know About Referrals - Medscape
Feb 26, 2025 · When it comes to risk management, prevention, and treatment of conditions like straight-forward hyperlipidemia, hypertension, and even coronary artery disease with …
Cardiac Risks With Newer Psoriasis Meds Match TNF Inhibitors
Jan 7, 2025 · A study of biologic-naive patients with psoriasis or PsA found that IL-17, IL-12/23, and IL-23 inhibitors have cardiovascular and thrombotic risk profiles comparable with those of …